← Open Payments lookup

JENNIFER JONES: Open Payments

NPI 1558752303 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,343 in 246 payments from 20 companies in 2025. Trend: 2023 $3,149 · 2024 $3,320 · 2025 $4,343

Food & beverage: $4,334Education: $9
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.58$813
Axsome Therapeutics, Inc.31$638
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$408
ABBVIE INC.22$341
Otsuka America Pharmaceutical, Inc.18$314
Janssen Pharmaceuticals, Inc11$238
Teva Pharmaceuticals USA, Inc.10$227
Lundbeck LLC12$214
Alkermes, Inc.14$188
Takeda Pharmaceuticals U.S.A., Inc.12$182

Products named: INGREZZA, Auvelity, REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR, ARISTADA, TRINTELLIX.

Industry payments across LA — which companies pay providers there.